R&D Series Nova Compo N
K-Number: K192178 · 2019-12-20
Decision Date2019-12-20
Product CodeEBF
Advisory CommitteeDE
DecisionSubstantially Equivalent
Device Summary
R&D Series Nova Compo N is a medical device manufactured by Imicryl Dis Malzemeleri Sanayi VE Ticaret AS. It received FDA 510(k) clearance on 2019-12-20 under approval number K192178. The device is classified under product code EBF. It was reviewed by the DE advisory panel. FDA Decision: Substantially Equivalent.
Frequently Asked Questions
What is the R&D Series Nova Compo N?
R&D Series Nova Compo N is a medical device that received FDA 510(k) clearance on 2019-12-20. It is manufactured by Imicryl Dis Malzemeleri Sanayi VE Ticaret AS. The 510(k) number is K192178.
When was R&D Series Nova Compo N approved by the FDA?
R&D Series Nova Compo N received FDA 510(k) clearance on 2019-12-20, under approval number K192178.
What company makes R&D Series Nova Compo N?
R&D Series Nova Compo N is manufactured by Imicryl Dis Malzemeleri Sanayi VE Ticaret AS.
What is the FDA product code for R&D Series Nova Compo N?
The FDA product code for R&D Series Nova Compo N is EBF.
Other Devices by Imicryl Dis Malzemeleri Sanayi VE Ticaret AS
Related Devices (Code: EBF)
K163207Filtek One Bulk Fill Restorative3M Company
K162537CAD/CAMouflage Milling BlockPrismatik Dentalcraft, Inc.
K160049CharismaHeraeus Kulzer, LLC (Mitsui Chemicals Group)
K162257P1145 Dental RestorativeKerr Corporation
K151399Capo Hybrid, Capo Slow Flow, Capo Flow, Capo Natural, Capo Universal, Nano Paq, Nano Paq FlowSchutz Dental GmbH
K162107TPH Spectra+ Universal Composite RestorativeDentsply Sirona
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.